Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 2
2010 1
2017 2
2018 1
2019 2
2020 3
2021 1
2022 1
2023 6
2024 1
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Acute pulmonary embolism: a multimarker calculator to predict short-term outcomes.
Jiménez D, Dubois-Silva Á, Demelo-Rodríguez P, Ruiz-Artacho P, López-Núñez JJ, Moisés J, Muriel A, Bura-Riviere A, Mahé I, Barillari G, Bikdeli B, Monreal M; RIETE Investigators. Jiménez D, et al. Eur Heart J. 2025 May 20:ehaf228. doi: 10.1093/eurheartj/ehaf228. Online ahead of print. Eur Heart J. 2025. PMID: 40391731
Presentation, care, and outcomes of patients with NSTEMI according to World Bank country income classification: the ACVC-EAPCI EORP NSTEMI Registry of the European Society of Cardiology.
Nadarajah R, Ludman P, Laroche C, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI investigator group. Nadarajah R, et al. Eur Heart J Qual Care Clin Outcomes. 2023 Sep 12;9(6):552-563. doi: 10.1093/ehjqcco/qcad008. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 36737420 Free PMC article.
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials.
Jenab Y, Sadeghipour P, Mohseni-Badalabadi R, Kaviani R, Hosseini K, Pasebani Y, Khederlou H, Rafati A, Mohammadi Z, Jamalkhani S, Talasaz AHH, Firouzi A, Ariannejad H, Alemzadeh-Ansari MJ, Ahmadi-Renani S, Maadani M, Farrashi M, Bakhshandeh H, Piazza G, Krumholz HM, Mehran R, Lip GYH, Bikdeli B. Jenab Y, et al. EuroIntervention. 2025 Jan 6;21(1):82-92. doi: 10.4244/EIJ-D-24-00527. EuroIntervention. 2025. PMID: 39773831 Free article.
Primary mediastinal myelolipoma.
Vaziri M, Sadeghipour A, Pazooki A, Shoolami LZ. Vaziri M, et al. Ann Thorac Surg. 2008 May;85(5):1805-6. doi: 10.1016/j.athoracsur.2007.11.023. Ann Thorac Surg. 2008. PMID: 18442597
Structure-Function Correlation of Deep-Learning Quantified Ellipsoid Zone and Retinal Pigment Epithelium Loss and Microperimetry in Geographic Atrophy.
Birner K, Reiter GS, Steiner I, Zarghami A, Sadeghipour A, Schürer-Waldheim S, Gumpinger M, Bogunovic H, Schmidt-Erfurth U. Birner K, et al. Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):26. doi: 10.1167/iovs.66.3.26. Invest Ophthalmol Vis Sci. 2025. PMID: 40067294 Free PMC article.
Increased EZT had a significant positive effect on PWS (0.34, 95% CI = 0.32 to 0.36 dB/m, P < 0.0001). Structure-function correlations were consistent throughout all levels of eccentricity with P < 0.001. ...

Increased EZT had a significant positive effect on PWS (0.34, 95% CI = 0.32 to 0.36 dB/m, P < 0.0001). Structure-function correlat

…
External validation of the VTE-PREDICT score for predicting recurrence and bleeding in venous thromboembolism: results from the Registro Informatizado Enfermedad TromboEmbὀlica Registry.
Hoberstorfer T, Nopp S, Steiner D, Hernández-Blasco L, Jou I, López-Núñez JJ, Fidalgo Á, López-Miguel P, Monreal M, Ay C; RIETE Investigators. Hoberstorfer T, et al. J Thromb Haemost. 2025 Aug 22:S1538-7836(25)00529-X. doi: 10.1016/j.jtha.2025.08.007. Online ahead of print. J Thromb Haemost. 2025. PMID: 40850342 Free article.
Prevalence and associated factors of chronic venous disease among the modern Iranian urban population.
Babaei M, Afrooghe A, Rafati A, Mohebbi B, Moosavi J, Ghadri N, Koohestani BM, Rahimi S, Baay M, Alemzadeh-Ansari MJ, Hosseini Z, Boudagh S, Khalilipur E, Ghaemmaghami Z, Pasebani Y, Firoozbakhsh P, Pouraliakbar H, Bakhshandeh H, Sadeghipour P. Babaei M, et al. J Vasc Surg Venous Lymphat Disord. 2023 Nov;11(6):1098-1106.e10. doi: 10.1016/j.jvsv.2023.06.005. Epub 2023 Sep 9. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 37690625 Free article.
A multivariable regression model was used to analyze the association between CVD and prespecified covariates of age, sex, body mass index (30 kg/m(2)), smoking, hypertension, diabetes mellitus, physical activity, dyslipidemia, and delivery method. ...
A multivariable regression model was used to analyze the association between CVD and prespecified covariates of age, sex, body mass index (3 …
Effect of posterior vitreous detachment on treat-and-extend versus monthly ranibizumab for neovascular age-related macular degeneration.
Waldstein SM, Coulibaly L, Riedl S, Sadeghipour A, Gerendas BS, Schmidt-Erfurth UM. Waldstein SM, et al. Br J Ophthalmol. 2020 Jul;104(7):899-903. doi: 10.1136/bjophthalmol-2019-314661. Epub 2019 Sep 28. Br J Ophthalmol. 2020. PMID: 31563866 Clinical Trial.
Conversely, mean change in CRT at month 12 was -174 (PVD) vs -173 m (no PVD, p=0.98) in the monthly arm, and -175 (PVD) vs -164 m (no PVD, p=0.58) in the T&E arm. ...
Conversely, mean change in CRT at month 12 was -174 (PVD) vs -173 m (no PVD, p=0.98) in the monthly arm, and -175 (PVD) vs -164 m …
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial.
Talasaz AH, Sadeghipour P, Bakhshandeh H, Sharif-Kashani B, Rashidi F, Beigmohammadi MT, Moghadam KG, Rezaian S, Dabbagh A, Sezavar SH, Farrokhpour M, Abedini A, Aliannejad R, Riahi T, Yadollahzadeh M, Lookzadeh S, Rezaeifar P, Matin S, Tahamtan O, Mohammadi K, Zoghi E, Rahmani H, Hosseini SH, Mousavian SM, Abri H, Sadeghipour P, Baghizadeh E, Rafiee F, Jamalkhani S, Amin A, Mohebbi B, Parhizgar SE, Soleimanzadeh M, Aghakouchakzadeh M, Eslami V, Payandemehr P, Khalili H, Talakoob H, Tojari T, Shafaghi S, Tabrizi S, Kakavand H, Kashefizadeh A, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Ansarin K, Maleki M, Sadeghian S, Barco S, Siegerink B, Spatz ES, Piazza G, Kirtane AJ, Tassell BWV, Lip GYH, Klok FA, Goldhaber SZ, Stone GW, Krumholz HM, Bikdeli B. Talasaz AH, et al. Thromb Haemost. 2023 Jul;123(7):723-733. doi: 10.1055/a-2059-4844. Epub 2023 Mar 21. Thromb Haemost. 2023. PMID: 36944357 Clinical Trial.
23 results